Keyphrases
Meta-analysis
100%
Chronic Kidney Disease
70%
Surabaya
67%
COVID-19
64%
ST-elevation Myocardial Infarction (STEMI)
53%
Chronic Kidney Disease Patients
52%
Hypertension
51%
Systematic Meta-analysis
50%
Indonesia
49%
COVID-19 Patients
46%
Acute Coronary Syndrome
43%
Cardiovascular Disease
37%
Cardiogenic Shock
35%
Gene Polymorphism
34%
Cardiovascular Mortality Risk
33%
Risk Factors
31%
Clinical Outcomes
30%
Mortality Prediction
30%
Cardiovascular Mortality
29%
Cardiovascular Risk
28%
Emergency Department
27%
Deep Vein Thrombosis
25%
U-Net
25%
Hypertensive
25%
Chest Pain
24%
Endothelial Dysfunction
23%
Single nucleotide Polymorphism
22%
Confidence Interval
22%
Myocardial Infarction
21%
Oxidative Stress
21%
Angiotensin-converting Enzyme
21%
Polymorphism
21%
Atherosclerotic Cardiovascular Disease (ASCVD)
21%
Hemodialysis
20%
Occlusion
20%
Unfractionated Heparin
20%
High-sensitivity C-reactive Protein (hs-CRP)
19%
Hemodialysis Patients
19%
Beta-blockers
18%
Myocarditis
18%
Poor Outcome
18%
Antihypertensive Drugs
18%
Venous Thromboembolism
18%
Angiotensin-converting Enzyme 2 (ACE2)
18%
Arterial Stiffness
18%
D-dimer
18%
Moxifloxacin
18%
Non-dialysis Chronic Kidney Disease
18%
Indonesian
18%
Referral Hospital
17%
QTc Interval
17%
Retrospective Cohort Study
17%
Acute Myocardial Infarction
16%
Tuberculosis Patients
16%
Rifampicin-resistant Tuberculosis
16%
Interleukin-6 Levels
16%
Black Cumin
16%
Arteriovenous Fistula
16%
Cigarette
16%
Electronic Cigarettes
16%
Denoising Filter
16%
Disease Progression
16%
Klotho
16%
8-hydroxydeoxyguanosine (8-OHdG)
16%
Carotid-femoral Pulse Wave Velocity (cfPWV)
16%
Oxidative Stress Markers
16%
Critically Ill COVID-19 Patients
16%
Adipose-derived Mesenchymal Stem Cells (ADMSCs)
16%
Arrhythmia
16%
Warfarin
16%
Left Main
16%
Atrial Septal Defect
16%
Infective Endocarditis
16%
Obese Adolescents
16%
Perindopril
16%
Human Adipocytes
16%
No Significant Difference
16%
Platelets
16%
Carotid Intima-media Thickness (cIMT)
15%
QRS Complex
15%
Troponin
15%
Coronary Artery Disease
15%
Non-ST-segment Elevation Acute Coronary Syndrome (NSTE-ACS)
15%
Mortality Rate
15%
Acute Heart Failure
15%
General Hospital
14%
Echocardiography
14%
Clinical Characteristics
14%
Odds Ratio
14%
Coronary Angiography
14%
Angiotensin-converting Enzyme Inhibitor (ACEi)
14%
Malondialdehyde
14%
Total Occlusion
14%
Cigarette Smoking
14%
Thrombus
14%
Genotype
13%
Treatment Group
13%
Length of Stay
13%
ST Elevation
13%
Heart Failure Patients
13%
Medicine and Dentistry
Systematic Review
100%
Meta-Analysis
83%
COVID-19
76%
Chronic Kidney Disease
55%
Electrocardiogram
53%
Cardiovascular Disease
48%
Myocardial Infarction
45%
Acute Coronary Syndrome
37%
Cardiogenic Shock
35%
Diagnosis
32%
Cross Sectional Study
31%
ST Elevation
29%
Thorax Pain
26%
Diseases
26%
Echocardiography
26%
Coronary Artery
25%
Emergency Department
25%
Biological Marker
25%
Venous Thromboembolism
25%
Cardiovascular Risk
23%
Electrocardiography
22%
ST Segment Elevation Myocardial Infarction
21%
Hemodialysis
20%
ST Segment
18%
Myocarditis
18%
Arterial Stiffness
18%
Coronary Angiography
17%
Cardiovascular Mortality
17%
Acute Heart Infarction
17%
Hemodynamic
16%
Arteriovenous Fistula
16%
Electronic Cigarette
16%
Infective Endocarditis
16%
Single Nucleotide Polymorphism
16%
DNA Polymorphism
16%
Prevalence
15%
Odds Ratio
15%
Mitral Insufficiency
14%
Atherosclerosis
14%
Observational Study
14%
Right Bundle Branch Block
13%
Combination Therapy
13%
Congestive Heart Failure
13%
Upper Limb
12%
Pulmonary Hypertension
12%
Atrial Septal Defect
11%
Coronary Artery Disease
11%
Rhythm
11%
Diastolic Blood Pressure
11%
Dyspnea
11%
Intima-Media Thickness
11%
Stenosis
11%
Coronary Occlusion
11%
QRS Complex
11%
Limb
11%
Creatinine
11%
Sepsis
10%
Dyslipidemia
10%
Shock (Circulatory)
10%
Primary Percutaneous Coronary Intervention
10%
Left Bundle Branch Block
10%
Neoplasm
10%
Malignant Neoplasm
9%
Neutrophil
9%
Acute Decompensated Heart Failure
9%
Cardiac Dysrhythmia
9%
Antihypertensive Agent
9%
Coagulopathy
9%
Thromboembolism
9%
Left Atrium
9%
Oxidative Stress
9%
D-Dimer
8%
Diabetes Mellitus
8%
Laboratory Test
8%
Mitral Valve
8%
C Reactive Protein
8%
Ventricular Septal Defect
8%
Thrombus Aspiration
8%
Homocysteine
8%
Carotid Atherosclerosis
8%
Circulating microRNA
8%
Calcium Channel Blocking Agent
8%
Chylopericardium
8%
End Stage Renal Disease
8%
Coronary Circulation
8%
Takotsubo Cardiomyopathy
8%
Coronary Artery Anomaly
8%
Blood Clotting Factor 10a Inhibitor
8%
Atrial Fibrillation
8%
Sleep Quality
8%
Posterior Myocardial Infarction
8%
Heart Ventricle Function
8%
Heart Muscle Ischemia
8%
Heparin-Induced Thrombocytopenia
8%
Artery Steal Syndrome
8%
Pulmonary Valve
8%
Simvastatin
8%
Fibrin Degradation Product
8%
Pleiotropy
8%
Fibrinogen Degradation Product
8%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
68%
Diseases
52%
Cardiovascular Disease
50%
Acute Coronary Syndrome
37%
Heparin
31%
Coronavirinae
29%
Biological Marker
28%
Antihypertensive Agent
28%
Cross-Sectional Study
27%
Angiotensin Converting Enzyme 2
26%
Observational Study
26%
Endothelial Dysfunction
26%
C Reactive Protein
25%
SARS Coronavirus
19%
Blood Clotting Disorder
19%
Ischemic Heart Disease
19%
Cardiogenic Shock
18%
Troponin
18%
Moxifloxacin
18%
Beta Adrenergic Receptor Blocking Agent
18%
Malignant Neoplasm
17%
Cardiovascular Mortality
17%
Congestive Heart Failure
17%
Cigarette Smoke
17%
Cohort Study
17%
Nigella sativa
16%
Drug Resistant Tuberculosis
16%
Rifampicin
16%
Heart Arrhythmia
16%
Venous Thromboembolism
16%
Disease Exacerbation
16%
Hypertension
16%
Warfarin
16%
Perindopril
16%
Cardiovascular Risk
16%
Prevalence
15%
Interleukin 6
15%
Mortality Rate
15%
Receptor
15%
Superoxide Dismutase
14%
Hospital Mortality
13%
Heart Infarction
13%
Coronary Artery Atherosclerosis
13%
Treatment Group
12%
ST Segment Elevation Myocardial Infarction
12%
Cytokine
12%
Atherosclerosis
12%
Pandemic
12%
Pulmonary Hypertension
12%
Malonaldehyde
12%
Bleeding
12%
Heart Atrium Septum Defect
11%
Sepsis
11%
Coronary Artery Disease
11%
Clinical Trial
11%
Thromboplastin
10%
D Dimer
10%
Dyslipidemia
10%
Myocarditis
10%
Low Molecular Weight Heparin
10%
Heparin Induced Thrombocytopenia
10%
Acute Heart Infarction
10%
Combination Therapy
10%
Creatinine
9%
Calcium Channel Blocker
9%
Side Effect
9%
Heart Disease
9%
Cerebrovascular Accident
9%
Acetylsalicylic Acid
9%
Troponin I
9%
8 Hydroxydeoxyguanosine
8%
Hemodialysis
8%
Dipeptidyl Carboxypeptidase Inhibitor
8%
Losartan
8%
Severe Acute Respiratory Syndrome
8%
Homocysteine
8%
Carotid Atherosclerosis
8%
Circulating microRNA
8%
Artery Disease
8%
Electronic Cigarette
8%
Prematurity
8%
End Stage Renal Disease
8%
N(g),n(g) Dimethylarginine
8%
6 N,n' Dimethylarginine
8%
Myofibrosis
8%
Blood Clotting Factor 10a Inhibitor
8%
Lung Edema
8%
Heart Ventricle Septum Defect
8%
Politef
8%
Brain Infarction
8%
Syndrome
8%
Anaphylaxis
8%
Enoxaparin
8%
Arteriovenous Fistula
8%
Fondaparinux
8%
Fibronectin
8%
Fibrinogen Degradation Product
8%
Fibrin Degradation Product
8%
Camellia Sinensis
8%
Leporidae
8%